Menu
Back to Journals » Vascular Health and Risk Management » Volume 12
Review
PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 10,062 | Dovepress* | 4,883 | 2,397+ | 1,455 | 7,280 |
| PubMed Central* | 0 | 2,782 | 934 | 2,782 | |
| Totals | 4,883 | 5,179 | 2,389 | 10,062 | |
|
*Since 9 May 2016 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 10 | 0 | 0 | 0 | 4 | 6 |
View citations on PubMed Central and Google Scholar